Muscle News and Research

RSS

Universal neuromuscular training helps avoid ACL sprains and tears

As participation in high-demand sports such as basketball and soccer has increased over the past decade, so has the number of anterior cruciate ligament (ACL) injuries in teens and young adults.

9 May 2014

Mice study shows specific energy source responsible for performing complex cognitive functions

New research suggests that certain types of brain cells may be "picky eaters," seeming to prefer one specific energy source over others.

9 May 2014

Sildenafil may help boys suffering from muscular dystrophy disease

Drugs used to treat erectile dysfunction may be able to slow disease progression in boys who suffer from the muscle wasting disease Duchenne muscular dystrophy.

8 May 2014

Finding has implications for understanding cognitive decline in degenerative diseases

New research suggests that certain types of brain cells may be "picky eaters," seeming to prefer one specific energy source over others. The finding has implications for understanding the cognitive decline seen in aging and degenerative diseases such as Alzheimer's and multiple sclerosis.

8 May 2014

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Cedars-Sinai Heart Institute researchers have found that a commonly prescribed drug restores blood flow to oxygen-starved muscles of boys with Duchenne muscular dystrophy, a genetic muscle-wasting disease that rarely is seen in girls but affects one in 3,500 male babies, profoundly shortening life expectancy. It is the most common fatal disease that affects children.

8 May 2014

Form of baclofen works better at treating narcolepsy

Neuroscientists at SRI International have found that a form of baclofen, a drug used to treat muscle spasticity, works better at treating narcolepsy than the best drug currently available when tested in mice.

8 May 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 May 2014

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Ligand Pharmaceuticals Incorporated today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.

7 May 2014

Rigel Pharmaceuticals reports net loss of $22.3 million for first quarter 2014

Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2014.

7 May 2014

Study focuses on mutated protein associated with early onset torsion dystonia

A collaborative discovery involving Kansas State University researchers may lead to the first universal treatment for dystonia, a neurological disorder that affects nearly half a million Americans.

7 May 2014

IKKβ links vascular inflammation to obesity and atherosclerosis development

A study in The Journal of Experimental Medicine shows that IκB kinase β (IKKβ) functions in smooth muscle cells to regulate vascular inflammatory responses and atherosclerosis development.

7 May 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals, Inc. today reported a pro forma net operating loss (NOL) of $22.6 million for the three months ended March 31, 2014 compared to pro forma operating income of $4.5 million for the same period in 2013.

6 May 2014

Family-based CBT benefits young children with Obsessive-Compulsive Disorder

A new study from the Bradley Hasbro Children's Research Center has found that family-based cognitive behavioral therapy (CBT) is beneficial to young children between the ages of five and eight with Obsessive-Compulsive Disorder (OCD).

6 May 2014

Novogen partners with Genea Biocells to accelerate testing for neurodegenerative diseases

Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.

5 May 2014

Calif. Medicaid backlog strands 900,000; Va. Gov. considers expansion without legislature

In California, 900,000 people are still awaiting final processing of their Medicaid applications. Meanwhile, the impasse over the budget and Medicaid expansion continues in Virginia and The Washington Post reports that Gov. Terry McAuliffe is examining legal strategies to make the move without legislative approval.

5 May 2014

ViSalus reports top line sales growth of $57.4M in first quarter 2014

ViSalus, the weight-loss and fitness company known for its mission of Challenging the world…10 lbs. at a time through the PROJECT 10™ Challenge, today announced first quarter 2014 sales of $57.4 million.

2 May 2014

First Edition: May 2, 2014

Today's headlines include coverage of the latest round of health insurance enrollment data released by the Obama administration.

2 May 2014

Newly discovered molecule provides drug target for controlling both asthma and cancerous tumor growth

A newly discovered molecule provides a new drug target for controlling both asthma-induced muscle thickening and cancerous tumor growth. This molecule, called "microRNA-10a," normally helps genes produce proteins or make copies of themselves, also play an important role in the growth or overgrowth of human airway smooth muscle cells and some forms of cancer.

2 May 2014

Richard M. Ross Heart Hospital docs implanted smallest heart pacemaker in Columbus woman

It's about the size of a large vitamin pill and, for the first time in Ohio, the smallest heart pacemaker available is being tested at The Ohio State University Wexner Medical Center.

From Medtronic 2 May 2014

Free educational event for patients with Graves' disease and thyroid eye disease

The Massachusetts Eye and Ear and the Graves' Disease & Thyroid Foundation will host a free educational event for patients living with Graves' disease and thyroid eye disease on Saturday, May 10 from 8:30 a.m. to noon at Mass. Eye and Ear's Meltzer Auditorium, 3rd floor, 243 Charles Street, Boston, Mass., 02114.

30 Apr 2014

Muscle News and Research

Universal neuromuscular training helps avoid ACL sprains and tears

Mice study shows specific energy source responsible for performing complex cognitive functions

Sildenafil may help boys suffering from muscular dystrophy disease

Finding has implications for understanding cognitive decline in degenerative diseases

Commonly used drug restores blood flow to oxygen-starved muscles of boys with muscular dystrophy

Form of baclofen works better at treating narcolepsy

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

Ligand's total revenues increase 37% to $16.0 million in first quarter 2014

Rigel Pharmaceuticals reports net loss of $22.3 million for first quarter 2014

Study focuses on mutated protein associated with early onset torsion dystonia

IKKβ links vascular inflammation to obesity and atherosclerosis development

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Family-based CBT benefits young children with Obsessive-Compulsive Disorder

Novogen partners with Genea Biocells to accelerate testing for neurodegenerative diseases

Calif. Medicaid backlog strands 900,000; Va. Gov. considers expansion without legislature

ViSalus reports top line sales growth of $57.4M in first quarter 2014

First Edition: May 2, 2014

Newly discovered molecule provides drug target for controlling both asthma and cancerous tumor growth

Richard M. Ross Heart Hospital docs implanted smallest heart pacemaker in Columbus woman

Free educational event for patients with Graves' disease and thyroid eye disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News